Valvular heart disease: Gender differences in clinical presentation and surgical outcome of aortic stenosis

Fuchs, Christina; Mascherbauer, Julia; Rosenhek, Raphael; Pernicka, Elisabeth; Klaar, Ursula; Scholten, Christine; Heger, Maria; Wollenek, Gregor; Czerny, Martin; Maurer, Gerald; Baumgartner, Helmut
April 2010
Heart;Apr2010, Vol. 96 Issue 8, p539
Academic Journal
Background Little is known about the gender differences of patients undergoing aortic valve replacement (AVR) for isolated severe aortic stenosis. Methods and Results 408 consecutive patients (215 women and 193 men; p=0.9) were analysed. At presentation, women were older (73.7�9.3 years vs men 66.5�11.5 years; p<0.001), more symptomatic (New York Heart Association (NYHA) class: women 2.3�0.7 vs men 2.0�0.65; p<0.001), and presented with smaller valve areas (women 0.6�0.2 cm� vs men 0.7�0.2 cm�; p<0.001) and higher mean pressure gradients (women 67.3�19.2 mm Hg vs men 62.2�20.0 mm Hg, p=0.001). Despite older age and more advanced disease in women, operative mortality did not differ. Survival after AVR by Kaplan-Meier analysis tended to be even better in women (92.8%, 89.8%, 81.4% vs men 89.1%, 86.6%, 76.3% at 1, 2 and 5 years, p=0.31). After division into age quintiles, the outcome of women was significantly better in patients older than 79 years (p=0.005). After adjustment for clinical characteristics, gender did not predict operative mortality and late outcome. Despite physical improvement in both groups after surgery, women remained more symptomatic (NYHA class: women 1.6�0.7 vs men 1.3�0.4; p=0.001). Conclusion Although women referred to AVR are older and more symptomatic, operative and long-term mortality are not increased. In the oldest age group of 79 years and older, women even have a better outcome, presumably due to a longer mean life expectancy.


Related Articles

  • Calcific aortic stenosis: same old story? Cowell, S. Joanna; Newby, David E.; Boon, Nicholas A.; Elder, Andrew T. // Age & Ageing;Nov2004, Vol. 33 Issue 6, p538 

    Calcific aortic stenosis is the commonest adult valvular heart condition seen in the western world. Its prevalence is continuing to rise, with predominance in older patients who are frequently undergoing successful aortic valve replacement. This review discusses the natural history of calcific...

  • Bicuspid aortic valves: increased morbidity but not mortality.  // Heart;Jan2009, Vol. 95 Issue 2, p171 

    The article discusses a study on the disease progression and cardiac outcomes of patients with bicuspid aortic valves. In a cohort study of 642 adults, 28 deaths occurred during the nine-year follow-up period, while 161 primary cardiac events occurred in 161 patients. Predictors of cardiac...

  • The Management of Valvular Heart Disease in Children. Folger, Gordon M. // Angiology;Jun1984, Vol. 35 Issue 6, p341 

    The child with significant valvular heart disease may present in any single instance both the most difficult of management decisions or a surprisingly simple one. Thus, if a direct surgical approach on the valve is feasible, the problems may very well be quite simple and straightforward;...

  • Two-Year Outcomes after Transcatheter or Surgical Aortic-Valve Replacement. Kodali, Susheel K.; Williams, Mathew R.; Smith, Craig R.; Svensson, Lars G.; Webb, John G.; Makkar, Raj R.; Fontana, Gregory P.; Dewey, Todd M.; Thourani, Vinod H.; Pichard, Augusto D.; Fischbein, Michael; Szeto, Wilson Y.; Lim, Scott; Greason, Kevin L.; Teirstein, Paul S.; Malaisrie, S. Chris; Douglas, Pamela S.; Hahn, Rebecca T.; Whisenant, Brian; Zajarias, Alan // New England Journal of Medicine;5/3/2012, Vol. 366 Issue 18, p1686 

    Background: The Placement of Aortic Transcatheter Valves (PARTNER) trial showed that among high-risk patients with aortic stenosis, the 1-year survival rates are similar with transcatheter aortic-valve replacement (TAVR) and surgical replacement. However, longer-term follow-up is necessary to...

  • Valvular heart diseases in Croatia in 2011. Mirat, Jure; Ćorić, Vedran; Bernat, Robert; Vrbanić, Luka; Vrljić, Dubravka; Vojković, Jakov; Biočina, Bojan; Korda, Ante Zvonimir; Medved, Igor; Ugljen, Ranko; Letica, Dalibor; Unić, Daniel // Kardio List;Mar/Apr2012, Vol. 7 Issue 3/4, p59 

    The article explores the overall incidence of valvular heart diseases in Croatia, as well as its comorbidity with other heart pathologies. Information on factors that influenced changes in the occurrence of acquired heart valve diseases is provided. The most common valvular pathology in the...

  • Almanac 2011: valvular heart disease. Rosenhek, Raphael // Kardio List;Mar/Apr2012, Vol. 7 Issue 3/4, p65 

    The article offers information on valvular heart disease (VHD). A study found that there was an association between calcific aortic valve disease and long-term exposure to raised cholesterol levels and active smoking. Another study found a link between improved long-term survival and early...

  • Cardiac Ochronosis. Erek, Ersin; Casselman, Filip P. A.; Vanermen, Hugo // Texas Heart Institute Journal;2004, Vol. 31 Issue 4, p445 

    Presents a medical case involving a woman diagnosed with alkaptonuria while undergoing cardiac surgery. Symptoms presented by the woman upon consultation; Events the lead to the diagnosis of alkaptonuria; Information on alkaptonuria.

  • Kapak hastalığına eÅŸlik eden koroner arter hastalığı. Yıldırır, Aylin // Anatolian Journal of Cardiology / Anadolu Kardiyoloji Dergisi;Jul2009 Supplement, Vol. 9, p10 

    Nowadays, age-related degenerative etiologies have largely replaced the rheumatic ones and as a natural result of this etiologic change, coronary artery disease has become associated with valvular heart disease to a greater extent. Degenerative aortic valve disease has an important...

  • Optimal pain management after aortic valve implantation: an opportunity to improve outcomes after transapical access in the future? Dworakowski, Rafal; Wendler, Olaf // Heart;Nov2012, Vol. 98 Issue 21, p1541 

    The article presents information regarding pain management after aortic valve implantation. It mentions that the transcatheter aortic valve implantation (TAVI) is considered as an alternative therapy for aortic stenosis. It informs that in a randomized controlled trial to study mortality risk...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics